Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aileen Ahiskali"'
Autor:
Jennifer L. Adema, Aileen Ahiskali, Madiha Fida, Krutika Mediwala Hornback, Ryan W. Stevens, Christina G. Rivera
Publikováno v:
Pathogens, Vol 13, Iss 3, p 190 (2024)
There was an error in the original publication [...]
Externí odkaz:
https://doaj.org/article/71c51e9441b444ff9b3e05f42b3d4e87
Autor:
Jennifer L. Adema, Aileen Ahiskali, Madiha Fida, Krutika Mediwala Hornback, Ryan W. Stevens, Christina G. Rivera
Publikováno v:
Pathogens, Vol 12, Iss 5, p 703 (2023)
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity and mortality, requiring antimicrobials and at times surgical intervention. Through the decades of healthcare professionals’ experience with managing IE, c
Externí odkaz:
https://doaj.org/article/49f4259c1a7c4a0f8dd2f76c9bd7cab8
Autor:
Aileen Ahiskali, Heather Rhodes
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Treatment of complicated infections in persons who inject drugs (PWID) and patients experiencing homelessness poses a unique challenge to clinicians. Long-acting lipoglycopeptide antibiotics, such as oritavancin, may facilitate ex
Externí odkaz:
https://doaj.org/article/2e51fa316ba94229befd5377806b80c3
Autor:
Christine M. Thomas, Jess Peterson, Aileen Ahiskali, Lina Hamid, Jessica Butts, Jennifer Czachura, Jonathan D. Alpern
Publikováno v:
Journal of the American Pharmacists Association. 62:1848-1854
The delivery of prompt and appropriate antimicrobial therapy for life-threatening infections is an important antimicrobial stewardship measure and a priority for hospitals.To better understand U.S. hospital pharmacy stocking processes and acquisition
Autor:
Heather Rhodes, Aileen Ahiskali
Publikováno v:
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-10 (2020)
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-10 (2020)
Background Treatment of complicated infections in persons who inject drugs (PWID) and patients experiencing homelessness poses a unique challenge to clinicians. Long-acting lipoglycopeptide antibiotics, such as oritavancin, may facilitate extended co